Switch from antibiotic eye drops to instillation of mother's milk drops as a treatment of infant epiphora.
In a paediatric practice, the management of patients with signs and symptoms of congenital nasolacrimal duct obstruction (CNLO) was switched from topical antibiotic to topical mother's milk (MM) -based regimens. The conservative management of this condition includes frequent cleansing of the lids, digital lacrimal sac massage, and application of topical antibiotic drops when there is a mucopurulent discharge. The method for managing CNLO has evolved in our office of paediatrics during the past 7 years. This change was initiated by some mothers who have applied traditional therapy: MM eye drops. This evolution has been accompanied by a number of articles from the mid 1990s into the 2000s on safety of MM eye drops in case of neonatal conjunctivitis, and on the anti-inflammatory characteristics and antibacterial activity of topical MM.
Verd
Sergio
S
D000890:Anti-Infective Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007766:Lacrimal Apparatus Diseases / Q000188:drug therapy*; D008297:Male; D008895:Milk, Human; D009883:Ophthalmic Solutions / Q000008:administration & dosage; D011379:Prognosis; D018709:Statistics, Nonparametric; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D009883:Ophthalmic Solutions